PUBMED

1. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.

Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N.

Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27.

PMID: 34715347

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548286/pdf/main.pdf

2. Omicron variant and booster COVID-19 vaccines.

Burki TK.

Lancet Respir Med. 2022 Feb;10(2):e17. doi: 10.1016/S2213-2600(21)00559-2. Epub 2021 Dec 17.

PMID: 34929158

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683118/pdf/main.pdf

3. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.

Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W.

Int J Infect Dis. 2022 Jan;114:252-260. doi: 10.1016/j.ijid.2021.11.009. Epub 2021 Nov 17.

PMID: 34800687

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595975/pdf/main.pdf

4. Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.

Zinatizadeh MR, Zarandi PK, Zinatizadeh M, Yousefi MH, Amani J, Rezaei N.

Biomed Pharmacother. 2022 Feb;146:112527. doi: 10.1016/j.biopha.2021.112527. Epub 2021 Dec 10.

PMID: 34906769

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660177/pdf/main.pdf

5. COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities.

Govender K, Nyamaruze P, McKerrow N, Meyer-Weitz A, Cowden RG.

BMJ Glob Health. 2022 Feb;7(2):e007839. doi: 10.1136/bmjgh-2021-007839.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844950/pdf/bmjgh-2021-007839.pdf

6. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.

Hoffmann M, Krüger N, Schulz S, Cossmann A, Rocha C, Kempf A, Nehlmeier I, Graichen L, Moldenhauer AS, Winkler MS, Lier M, Dopfer-Jablonka A, Jäck HM, Behrens GMN, Pöhlmann S.

Cell. 2022 Feb 3;185(3):447-456.e11. doi: 10.1016/j.cell.2021.12.032. Epub 2021 Dec 24.

PMID: 35026151 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702401/pdf/main.pdf

7. Innovations and development of Covid-19 vaccines: A patent review.

Alshrari AS, Hudu SA, Imran M, Asdaq SMB, Ali AM, Rabbani SI.

J Infect Public Health. 2022 Jan;15(1):123-131. doi: 10.1016/j.jiph.2021.10.021. Epub 2021 Oct 23.

PMID: 34742639

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539827/pdf/main.pdf

8. Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening.

Tande AJ, Pollock BD, Shah ND, Farrugia G, Virk A, Swift M, Breeher L, Binnicker M, Berbari EF.

Clin Infect Dis. 2022 Jan 7;74(1):59-65. doi: 10.1093/cid/ciab229.

PMID: 33704435 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989519/pdf/ciab229.pdf

9. Covid-19 Vaccine Effectiveness in New York State.

Rosenberg ES, Dorabawila V, Easton D, Bauer UE, Kumar J, Hoen R, Hoefer D, Wu M, Lutterloh E, Conroy MB, Greene D, Zucker HA.

N Engl J Med. 2022 Jan 13;386(2):116-127. doi: 10.1056/NEJMoa2116063. Epub 2021 Dec 1.

PMID: 34942067 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693697/pdf/NEJMoa2116063.pdf

10. COVID-19 vaccines and skin manifestations.

Bataille V, Puig S.

Br J Dermatol. 2022 Jan;186(1):15. doi: 10.1111/bjd.20807. Epub 2021 Nov 2.

PMID: 34726781

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653104/pdf/BJD-9999-0.pdf

11. COVID-19 vaccination for children with cancer.

Kotecha RS.

Pediatr Blood Cancer. 2022 Feb;69(2):e29340. doi: 10.1002/pbc.29340. Epub 2021 Sep 14.

PMID: 34519421

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662031/pdf/PBC-9999-0.pdf

12. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.

Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH.

J Cutan Pathol. 2022 Jan;49(1):34-41. doi: 10.1111/cup.14104. Epub 2021 Aug 8.

PMID: 34292611 Free PMC article.

CUP-9999-0.pdf

SCIENCEDIRECT

1. Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2

Journal of Molecular Structure, 13 August 2021, Volume 1247 (Cover date: 5 January 2022), Article 131296

Haroon ur Rashid, Nasir Ahmad, Samah Shabana

https://www.sciencedirect.com/science/article/pii/S0022286021014253/pdfft?md5=0ff45dde50eeefff3a8a57fca582091c&pid=1-s2.0-S0022286021014253-main.pdf

2. Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies

Saudi Journal of Biological Sciences, 17 September 2021, Volume 29, Issue 1 (Cover date: January 2022), Pages 526-533

Alhumaidi B. Alabbas, Mubarak A. Alamri

https://www.sciencedirect.com/science/article/pii/S1319562X21008299/pdfft?md5=4ef1daad9e159c27356b952be642719e&pid=1-s2.0-S1319562X21008299-main.pdf

3. On the deformation and frequency analyses of SARS-CoV-2 at nanoscale

International Journal of Engineering Science, 29 October 2021, Volume 170 (Cover date: 1 January 2022), Article 103604

Shahriar Dastjerdi, Mohammad Malikan, Victor A. Eremeyev

https://www.sciencedirect.com/science/article/pii/S0020722521001440/pdfft?md5=afb1f2b98782be6d048d075b82f4dcf2&pid=1-s2.0-S0020722521001440-main.pdf

4. Paper-based immunoassay based on 96-well wax-printed paper plate combined with magnetic beads and colorimetric smartphone-assisted measure for reliable detection of SARS-CoV-2 in saliva

Biosensors and Bioelectronics, 23 December 2021, Volume 200 (Cover date: 15 March 2022), Article 113909

Laura Fabiani, Vincenzo Mazzaracchio, Fabiana Arduini

https://www.sciencedirect.com/science/article/pii/S0956566321009465/pdfft?md5=6180390bbaac7613b1ff96bc10dd3de8&pid=1-s2.0-S0956566321009465-main.pdf

5. Synthesis and investigation of anti-COVID19 ability of ferrocene Schiff base derivatives by quantum chemical and molecular docking

Journal of Molecular Structure, 24 December 2021, Volume 1253 (Cover date: 5 April 2022), Article 132242

Ghulam Abbas, Ahmad Irfan, Renjith Thomas

https://www.sciencedirect.com/science/article/pii/S0022286021023620/pdfft?md5=aad361e9e957b2adb7de789491520c5c&pid=1-s2.0-S0022286021023620-main.pdf

6. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020

International Journal of Infectious Diseases, 12 October 2021, Volume 114 (Cover date: January 2022), Pages 21-28

Kevin B. Spicer, Connor Glick, Douglas Thoroughman

https://www.sciencedirect.com/science/article/pii/S1201971221008006/pdfft?md5=782d98aca4e04c3a8fea0e5cdca480e6&pid=1-s2.0-S1201971221008006-main.pdf

7. Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition

Journal of Molecular Graphics and Modelling, 11 October 2021, Volume 110 (Cover date: January 2022), Article 108050

Julia Liang, Eleni Pitsillou, Tom C. Karagiannis

https://www.sciencedirect.com/science/article/pii/S1093326321002217/pdfft?md5=d2b763da9bdd3f447a56d1298723232f&pid=1-s2.0-S1093326321002217-main.pdf

8. In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease

Journal of Ayurveda and Integrative Medicine, 25 February 2021, Volume 13, Issue 1 (Cover date: January-March 2022), Article 100413

Thrigulla Saketh Ram, Manne Munikumar, K. S. Dhiman

https://www.sciencedirect.com/science/article/pii/S097594762100019X/pdfft?md5=8a07a7e7d7fd4429d8c9f8a4e0b43ab9&pid=1-s2.0-S097594762100019X-main.pdf

9. SPEEDS: A portable serological testing platform for rapid electrochemical detection of SARS-CoV-2 antibodies

Biosensors and Bioelectronics, 1 November 2021, Volume 197 (Cover date: 1 February 2022), Article 113762

Ran Peng, Yueyue Pan, Xinyu Liu

https://www.sciencedirect.com/science/article/pii/S0956566321007995/pdfft?md5=441cc385f8e93b4125feda2ef6a81b3e&pid=1-s2.0-S0956566321007995-main.pdf

10. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice

eBioMedicine, 31 December 2021, Volume 75 (Cover date: January 2022), Article 103803

Jianxiong Zeng, Xiaochun Xie, Yong-Gang Yao

https://www.sciencedirect.com/science/article/pii/S2352396421005971/pdfft?md5=789a5657f59459aae20424d11addeac9&pid=1-s2.0-S2352396421005971-main.pdf

11. Anticipating hopes, fears and expectations towards COVID-19 vaccines: A qualitative interview study in seven European countries

SSM - Qualitative Research in Health, 4 January 2022, Volume 2 (Cover date: December 2022), Article 100035

Katharina T. Paul, Bettina M. Zimmermann, Ine Van Hoyweghen

https://www.sciencedirect.com/science/article/pii/S2667321521000354/pdfft?md5=dcdb7d3ae567db189dd9f8be75f7a700&pid=1-s2.0-S2667321521000354-main.pdf

12. Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK

The Lancet Regional Health - Europe, 3 February 2022, Volume 14 (Cover date: March 2022), Article 100317

Elise Paul, Daisy Fancourt

https://www.sciencedirect.com/science/article/pii/S2666776222000102/pdfft?md5=910df5c0b1317fa83dc31be9a2c95cfe&pid=1-s2.0-S2666776222000102-main.pdf

13. Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities

Vaccine, 27 December 2021, Volume 40, Issue 5 (Cover date: 31 January 2022), Pages 734-741

Samta Shukla, Francois Fressin, Sreekanth K. Chaguturu

https://www.sciencedirect.com/science/article/pii/S0264410X21016571/pdfft?md5=33339323919ae549cdbef496c98e709b&pid=1-s2.0-S0264410X21016571-main.pdf

14. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

Clinical Microbiology and Infection, 5 October 2021, Volume 28, Issue 2 (Cover date: February 2022), Pages 279-284

Eliseo Albert, Javier S. Burgos, David Navarro

https://www.sciencedirect.com/science/article/pii/S1198743X21005607/pdfft?md5=86eedbffdd2b79c1e8f6acbcb58ce863&pid=1-s2.0-S1198743X21005607-main.pdf

15. COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes

Vaccine, 17 January 2022, Volume 40, Issue 7 (Cover date: 11 February 2022), Pages 970-976

Leàn Rolfes, Linda Härmark, Florence van Hunsel

https://www.sciencedirect.com/science/article/pii/S0264410X22000287/pdfft?md5=3bb65bbf2c3a0af3f6d633e9cd06ae43&pid=1-s2.0-S0264410X22000287-main.pdf

16. Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccines

Medical Hypotheses, 3 January 2022, Volume 159 (Cover date: February 2022), Article 110756

Peter A. Feldman

https://www.sciencedirect.com/science/article/pii/S0306987721002759/pdfft?md5=45171c8205e827f11d903c76a3587fb1&pid=1-s2.0-S0306987721002759-main.pdf

17. Cov19VaxKB: A web-based integrative COVID-19 vaccine knowledge base

Vaccine: X, 28 December 2021, Volume 10 (Cover date: April 2022), Article 100139

Philip C. Huang, Rohit Goru, Yongqun He

https://www.sciencedirect.com/science/article/pii/S2590136221000565/pdfft?md5=3f739419f93b76ce6c7980e83463fceb&pid=1-s2.0-S2590136221000565-main.pdf

18. Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England

The Lancet Regional Health - Europe, 13 December 2021, Volume 13 (Cover date: February 2022), Article 100260

Nick J Andrews, Julia Stowe, Elizabeth Miller

https://www.sciencedirect.com/science/article/pii/S2666776221002465/pdfft?md5=6e2dc644f4da9eca36e8d28a88e93ae9&pid=1-s2.0-S2666776221002465-main.pdf

19. Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation

Vaccine, 16 December 2021, Volume 40, Issue 4 (Cover date: 28 January 2022), Pages 594-600

Samantha J. Carlson, Lara McKenzie, Katie Attwell

https://www.sciencedirect.com/science/article/pii/S0264410X21016297/pdfft?md5=555f92a204c7cbe0650256fd44e60d20&pid=1-s2.0-S0264410X21016297-main.pdf

20. COVID-19 vaccine acceptance in South Asia: a multi-country study

International Journal of Infectious Diseases, 28 September 2021, Volume 114 (Cover date: January 2022), Pages 1-10

Mohammad Delwer Hossain Hawlader, Mohammad Lutfor Rahman, Mohammad Hayatun Nabi

https://www.sciencedirect.com/science/article/pii/S1201971221007591/pdfft?md5=3ce84430f299412251af184b6f407803&pid=1-s2.0-S1201971221007591-main.pdf

SPRINGER NATURE

1. Covid-19-vaccine-pfizer-biontech

Reactions Weekly (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40278-022-07895-x.pdf

2. A review of the safety and efficacy of current COVID-19 vaccines

Zehong Huang, Yingying Su, Tianying Zhang, Ningshao Xia in Frontiers of Medicine (2022)

https://link.springer.com/content/pdf/10.1007%2Fs11684-021-0893-y.pdf

3. Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study

Philippe Hanna, Aline Issa, Ziad Noujeim… in Journal of Pharmaceutical Policy and Pract… (2022)

https://link.springer.com/content/pdf/10.1186%2Fs40545-021-00403-x.pdf

4. Coronavirus Disease 2019 (COVID-19) Vaccination for Children: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices

Dr Srinivas G. Kasi, Shashi Kant Dhir, Abhay Shah, S. Shivananda… in Indian Pediatrics (2022)

https://link.springer.com/content/pdf/10.1007%2Fs13312-022-2421-9.pdf

5. Correction to: Optimal control analysis of COVID-19 vaccine epidemic model: a case study

Arshad Alam Khan, Saif Ullah, Rohul Amin in The European Physical Journal Plus (2022)

https://link.springer.com/content/pdf/10.1140%2Fepjp%2Fs13360-022-02420-4.pdf

6. Covid-19-vaccine/influenza-virus-vaccine

Reactions Weekly (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40278-022-08484-3.pdf

7. Insights on Epidemiology, Pathogenesis, Diagnosis and Possible Treatment of COVID-19 Infection

Shashank Kumar Maurya, Amit Bhattacharya… in Proceedings of the National Academy of Sci… (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40011-021-01319-x.pdf

8. Spectrum of neurological complications following COVID-19 vaccination

Ravindra Kumar Garg, Vimal Kumar Paliwal in Neurological Sciences (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10072-021-05662-9.pdf

9. Practice report: an Alberta Métis model for COVID-19 vaccine delivery

Keith D. King, Reagan Bartel, Ashton James… in Canadian Journal of Public Health (2022)

https://link.springer.com/content/pdf/10.17269%2Fs41997-021-00603-7.pdf

10. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia

Metadel Adane, Ayechew Ademas, Helmut Kloos in BMC Public Health (2022)

https://link.springer.com/content/pdf/10.1186%2Fs12889-021-12362-8.pdf

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 11/02 đến ngày 18/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/covid-19-va-nhung-tac-dong-doi-voi-doi-song-ngay-11-18-2-2022-4685.html

Cập nhật các công bố về COVID-19 từ ngày 04/02 đến ngày 11/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-covid-19-tu-ngay-4-2-den-ngay-11-2-2022-4664.html

Cập nhật các công bố về COVID-19 từ ngày 21/01 đến ngày 28/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-21-01-den-ngay-28-01-2022-4639.html

Cập nhật các công bố về COVID-19 từ ngày 14/01 đến ngày 21/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-14-1-den-ngay-21-1-2022-4618.html

Cập nhật các công bố về COVID-19 từ ngày 7/01 đến ngày 14/01/2022